As of 2025-07-14, the Relative Valuation of Ironwood Pharmaceuticals Inc (IRWD) is (0.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.75 USD, the upside of Ironwood Pharmaceuticals Inc based on Relative Valuation is -118.1%.
The range of the Relative Valuation is (3.25) - 4.65 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 24.2x | 20.2x |
| Forward P/E multiples | 17.8x - 28.8x | 23.3x |
| Fair Price | (3.25) - 4.65 | (0.14) |
| Upside | -531.5% - 517.8% | -118.1% |
| Date | P/E |
| 2025-07-11 | -3.76 |
| 2025-07-10 | -3.88 |
| 2025-07-09 | -4.02 |
| 2025-07-08 | -3.78 |
| 2025-07-07 | -3.57 |
| 2025-07-03 | -3.83 |
| 2025-07-02 | -3.70 |
| 2025-07-01 | -3.51 |
| 2025-06-30 | -3.59 |
| 2025-06-27 | -3.66 |
| 2025-06-26 | -3.89 |
| 2025-06-25 | -3.75 |
| 2025-06-24 | -3.63 |
| 2025-06-23 | -3.37 |
| 2025-06-20 | -3.51 |
| 2025-06-18 | -3.50 |
| 2025-06-17 | -3.17 |
| 2025-06-16 | -3.34 |
| 2025-06-13 | -3.10 |
| 2025-06-12 | -3.34 |
| 2025-06-11 | -3.61 |
| 2025-06-10 | -4.00 |
| 2025-06-09 | -2.93 |
| 2025-06-06 | -3.04 |
| 2025-06-05 | -2.86 |
| 2025-06-04 | -3.01 |
| 2025-06-03 | -3.05 |
| 2025-06-02 | -3.11 |
| 2025-05-30 | -3.00 |
| 2025-05-29 | -3.16 |
| 2025-05-28 | -2.96 |
| 2025-05-27 | -3.11 |
| 2025-05-23 | -2.83 |
| 2025-05-22 | -3.10 |
| 2025-05-21 | -2.95 |
| 2025-05-20 | -3.26 |
| 2025-05-19 | -3.06 |
| 2025-05-16 | -2.85 |
| 2025-05-15 | -2.97 |
| 2025-05-14 | -3.25 |
| 2025-05-13 | -3.42 |
| 2025-05-12 | -3.67 |
| 2025-05-09 | -3.55 |
| 2025-05-08 | -3.50 |
| 2025-05-07 | -3.96 |
| 2025-05-06 | -4.64 |
| 2025-05-05 | -4.64 |
| 2025-05-02 | -4.66 |
| 2025-05-01 | -4.56 |
| 2025-04-30 | -4.66 |